PALO ALTO, Calif. and BOSTON, June 5, 2019 /PRNewswire/ — Patients facing serious, life-limiting illness benefit significantly from having conversations with their clinicians about their goals, values and preferences. Too often, however, clinicians face barriers in having these conversations reliably and consistently for all patients. A new partnership between Vynca, a provider of advance care planning technology solutions, and health system innovation center Ariadne Labs will make it easier for clinicians and patients to have these important conversations.
The partnership between Vynca and Ariadne Labswill offer Vynca clients the ability to electronically complete and share the Serious Illness Conversation Guide, developed by palliative care experts in the Ariadne Labs Serious Illness Program. The guide provides a structured framework that enables clinicians and patients to engage in sensitive and effective conversations about the patient’s prognosis and illness understanding, values and personal goals. In a recently published study, Ariadne Labs demonstrated that serious illness conversations with the guide reduced by half the proportion of patients with serious to moderate anxiety and depression.
The guide will be embedded in Vynca’s end-to-end solution that supports health care organizations to implement and scale high-quality advance care planning so that every person’s care preferences are honored at the end-of-life. Vynca technology supports education and engagement in advance care planning conversations, shared decision making, electronic completion of documents, and makes these documents electronically available to individuals, their family members, and health care providers across the care continuum. Partnering with over 80 hospitals, as well as health plans, ACOs, and state registries, these organizations are realizing an impact in terms of higher quality of care at the end-of-life and the avoidance of unwanted health care interventions.
“As part of our ongoing commitment to support individuals with serious illness, we’re excited Ariadne Labs is the first partner we have incorporated into our platform,” stated Ryan Van Wert, M.D., co-founder and CEO of Vynca. “The Serious Illness Conversation Guide assists clinicians in gaining a thorough understanding of an individual’s goals and preferences in order to inform future care decisions. Making this electronically available on our platform supports health care organizations to easily implement this valuable tool at scale. It also ensures health care providers have immediate access to all advance care planning documents in a single location, so they can ultimately honor end-of-life wishes.”